BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 32482835)

  • 1. Reductions in bilateral transverse sinus pressure gradients with unilateral transverse venous sinus stenting for idiopathic intracranial hypertension.
    Larson A; Rinaldo L; Chen JJ; Cutsforth-Gregory J; Theiler AR; Brinjikji W
    J Neurointerv Surg; 2021 Feb; 13(2):187-190. PubMed ID: 32482835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transverse venous stenting for the treatment of idiopathic intracranial hypertension, or pseudotumor cerebri.
    Cappuzzo JM; Hess RM; Morrison JF; Davies JM; Snyder KV; Levy EI; Siddiqui AH
    Neurosurg Focus; 2018 Jul; 45(1):E11. PubMed ID: 29961386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for failed transverse sinus stenting in pseudotumor cerebri patients.
    Goodwin CR; Elder BD; Ward A; Orkoulas-Razis D; Kosztowski TA; Hoffberger J; Moghekar A; Radvany M; Rigamonti D
    Clin Neurol Neurosurg; 2014 Dec; 127():75-8. PubMed ID: 25459247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contralateral approach to transverse-sigmoid sinus stenting.
    Gordon W; Abraham M
    Interv Neuroradiol; 2020 Oct; 26(5):658-663. PubMed ID: 32862754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transverse sinus stenting for idiopathic intracranial hypertension: a review of 52 patients and of model predictions.
    Ahmed RM; Wilkinson M; Parker GD; Thurtell MJ; Macdonald J; McCluskey PJ; Allan R; Dunne V; Hanlon M; Owler BK; Halmagyi GM
    AJNR Am J Neuroradiol; 2011 Sep; 32(8):1408-14. PubMed ID: 21799038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venous Sinus Stenting in Idiopathic Intracranial Hypertension: Results of a Prospective Trial.
    Dinkin MJ; Patsalides A
    J Neuroophthalmol; 2017 Jun; 37(2):113-121. PubMed ID: 27556959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pattern of pressure gradient alterations after venous sinus stenting for idiopathic intracranial hypertension predicts stent-adjacent stenosis: a proposed classification system.
    Raper D; Buell TJ; Ding D; Chen CJ; Starke RM; Liu KC
    J Neurointerv Surg; 2018 Apr; 10(4):391-395. PubMed ID: 28637822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dural sinus stenting for idiopathic intracranial hypertension: factors associated with hemodynamic failure and management with extended stenting.
    Kumpe DA; Seinfeld J; Huang X; Mei Q; Case DE; Roark CD; Subramanian PS; Lind KE; Pelak VS; Bennett JL
    J Neurointerv Surg; 2017 Sep; 9(9):867-874. PubMed ID: 27935482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fifty shades of gradients: does the pressure gradient in venous sinus stenting for idiopathic intracranial hypertension matter? A systematic review.
    McDougall CM; Ban VS; Beecher J; Pride L; Welch BG
    J Neurosurg; 2018 Mar; 130(3):999-1005. PubMed ID: 29498569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superior Ophthalmic Vein Flow Patterns as a Marker of Venous Sinus Stenosis and Hypertension in Idiopathic Intracranial Hypertension: A Case of Emergent Transverse Sinus Stenting as Treatment of Fulminant Idiopathic Intracranial Hypertension.
    Mugge L; Dang D; Curry B; Whiting R; Crimmins M
    World Neurosurg; 2022 May; 161():170-178. PubMed ID: 34224883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dural sinus stent placement for idiopathic intracranial hypertension.
    Kumpe DA; Bennett JL; Seinfeld J; Pelak VS; Chawla A; Tierney M
    J Neurosurg; 2012 Mar; 116(3):538-48. PubMed ID: 22149379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Endovascular stenting for idiopathic intracranial hypertension with different types of venous sinus stenosis].
    Su H; Zhang RJ; Cao XY; Liu XF; Du ZH; Li BM; Wang J
    Zhonghua Nei Ke Za Zhi; 2021 Aug; 60(8):728-733. PubMed ID: 34304448
    [No Abstract]   [Full Text] [Related]  

  • 13. Visual and neurological outcomes following endovascular stenting for pseudotumor cerebri associated with transverse sinus stenosis.
    Radvany MG; Solomon D; Nijjar S; Subramanian PS; Miller NR; Rigamonti D; Blitz A; Gailloud P; Moghekar A
    J Neuroophthalmol; 2013 Jun; 33(2):117-22. PubMed ID: 23502837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endovascular stenting for idiopathic intracranial hypertension with venous sinus stenosis.
    Liu X; Di H; Wang J; Cao X; Du Z; Zhang R; Yu S; Li B
    Brain Behav; 2019 May; 9(5):e01279. PubMed ID: 30950244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of CT venography in monitoring stent patency in idiopathic intracranial hypertension: retrospective single-center study.
    Shlapak DP; Lanzino G; Morris PP; Theiler AR; Brinjikji W
    J Neurointerv Surg; 2021 May; 13(5):478-482. PubMed ID: 32769112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. General Anesthesia Alters Intracranial Venous Pressures During Transverse Sinus Stenting.
    El Mekabaty A; Gottschalk A; Moghekar A; Obusez E; Khan M; Chung C; Spiotta A; Luciano MG; Hui FK
    World Neurosurg; 2020 Jun; 138():e712-e717. PubMed ID: 32194272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venous sinus stenting for reduction of intracranial pressure in IIH: a prospective pilot study.
    Liu KC; Starke RM; Durst CR; Wang TR; Ding D; Crowley RW; Newman SA
    J Neurosurg; 2017 Nov; 127(5):1126-1133. PubMed ID: 28009240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idiopathic Intracranial Venous Hypertension: Toward a Better Understanding of Venous Stenosis and the Role of Stenting in Idiopathic Intracranial Hypertension.
    Dinkin MJ; Patsalides A
    J Neuroophthalmol; 2023 Dec; 43(4):451-463. PubMed ID: 37410913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Which is the best peri-operative anti-coagulative therapy of transverse sinus stenting for refractory idiopathic intracranial hypertension?
    Mei QY; Xiao WZ; Chen HR; Bai RL; Sun KH; Hou LJ
    Chin Med J (Engl); 2012 Aug; 125(16):2951-3. PubMed ID: 22932099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transverse venous sinus stenting for idiopathic intracranial hypertension: Safety and feasibility.
    Koovor JM; Lopez GV; Riley K; Tejada J
    Neuroradiol J; 2018 Oct; 31(5):513-517. PubMed ID: 29882475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.